Clinical trials
Terminated Phase 1/2 trials in Greece
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 1 |
| BerGenBio ASA | 1 |
| Celgene | 1 |
| Genmab | 1 |
| Hellenic Oncology Research Group | 1 |
| Hoffmann-La Roche | 1 |
| Pharmacyclics LLC. | 1 |
| Teva Branded Pharmaceutical Products R&D LLC | 1 |
| University of Athens | 1 |
| Xencor, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 4 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Recurrence | 2 |
| Adenocarcinoma of Lung | 1 |
| Carcinoma, Ovarian Epithelial | 1 |
| Carcinoma, Transitional Cell | 1 |
| Cholangiocarcinoma | 1 |
| Leukemia, Myeloid, Acute | 1 |
| Lymphoma, Large B-Cell, Diffuse | 1 |
| Shock, Septic | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.